Search

everythinglearnresearchcommunity

for

Search:↓

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Curcumin can protect against mercury's harmful effects on brain and behavior.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.

The ointment is a safe, effective, and well-tolerated treatment for certain types of psoriasis.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

The new human placental extract may help prevent hair graying and reduce nerve pain from chemotherapy.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Hair changes can indicate systemic diseases or medication effects.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Using bacitracin zinc and selenium sulfide one after the other can temporarily turn white hair yellow.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Heptaminol may cause hair lightening in hemodialysis patients.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Certain drugs may cause vitiligo, so patients should be monitored.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Premature graying of hair is common and stressful, but not well understood or treated.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.